AdPha partners with Therapeutic Guidelines to deliver obesity clinical guidance

Advanced Pharmacy Australia (AdPha) has partnered with Therapeutic Guidelines to deliver AdPha’s new clinical resource, ObesiD. The resource offers concise evidence-based advice on more than 70 medicines and guidance on dosage adjustment principles to support use of medicines in patients with obesity.

AdPha’s ObesiD is available on desktop and mobile apps from 16 March, powered by Therapeutic Guidelines’ technology platform. Users with access to Therapeutic Guidelines will now be able to seamlessly switch between products.

Approximately one-third of Australian adults live with obesity, and a further 30% are overweight, figures that AdPha said show why a dedicated guide to equip healthcare professionals with evidence-based strategies to tailor patient treatment is essential.

ObesiD. Source: Therapeutic Guidelines

“This partnership represents an exciting and innovative step forward in Australian health publishing,” Therapeutic Guidelines CEO Dr Leigh-Anne Claase said. “By working closely with AdPha, we can bring vital guidance to even more health professionals nationwide. We will continue to provide resources that are not only reliable and evidence-based, but also more accessible and user friendly for the Australian healthcare community.”

The partnership will also encompass the upcoming launch of a redesigned and improved Don’t Rush to Crush, a guide to safely administering oral medicines to people with enteral feeding tubes or swallowing difficulties, AdPha said.

Top image credit: iStock.com/Mykola Sosiukin